Table 2:

Primary efficacy outcome

	Randomization
	ASMO (n = 139) (No.) (%)	FD (n = 139) (No.) (%)
Poor outcome	62 (44.6%)^a	43 (30.9%)
Clinical	13 (9.4%)	12 (8.6%)
mRS >2^{^b}	13 (9.4%)	10 (7.2%)
Aneurysm rupture	0	2 (1.4%)
Angiographic	49 (35.3%)	31 (22.3%)
Retreatment	7 (5.0%)	5 (3·6%)
Immediate failure^{^c}	8 (5.8%)	7 (5.0%)
Residual aneurysm	34 (24.5%)	19 (13.7%)
Good outcome	74 (53.2%)	96 (69.1%)
Angiographic	74 (53.2%)	96 (69.1%)
Complete occlusion	60 (43.2%)	85 (61.2%)
Residual neck	14 (10.1%)	11 (7.9%)
Not available	3 (2.2%)	0

a It is 45.6% (62/136) when adjusting for missing data.
↵b Comprises 14 deaths (ASMO = 9/FD = 5).
↵c Immediate treatment failures are treatments that were attempted but failed, with no further angiographic follow-up.